Literature DB >> 18619918

High prevalence of functional liver derangement in visceral leishmaniasis at an Indian tertiary care center.

Purva Mathur1, Jyotish Chandra Samantaray, Palash Samanta.   

Abstract

BACKGROUND & AIMS: Functional derangement of liver in visceral leishmaniasis is reported infrequently in the literature. Because of this, many cases are wrongly diagnosed and treated as hepatitis. We therefore envisaged to assess the actual magnitude of liver function derangement in confirmed cases of visceral leishmaniasis at our hospital.
METHODS: All confirmed kala-azar cases presenting over a period of 3 years at our tertiary care hospital were included in the study. A detailed assessment of their liver functions was performed at the time of diagnosis and at various intervals until their discharge.
RESULTS: A total of 114 cases of microscopy-confirmed visceral leishmaniasis were included in the study. Of these, 15 (13%) had jaundice at the time of presentation, 58 (51%), 37 (32%), 27 (24%), and 24 (21%) had increased levels of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and bilirubin, respectively. Eleven of the 114 cases had a fatal outcome, of whom 9 (82%) had some form of functional hepatic derangement.
CONCLUSIONS: Thus, in our study, functional derangement of liver was found to be common in patients with visceral leishmaniasis. In some cases, hepatitis confounded and delayed the diagnosis of kala-azar.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619918     DOI: 10.1016/j.cgh.2008.04.033

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  8 in total

1.  Lactate dehydrogenase (LD), alkaline phosphatase (ALP) isoenzymatic patterns in Iraqi children with visceral leishmaniasis before and after treatment with stibogluconate.

Authors:  Jasim Hameed Taher; Yassir Mustafa Kamal Al-Mulla Hummadi; Nada Muhammed Taha Al-Bashir; Ali Shaalan Al-Araji
Journal:  J Parasit Dis       Date:  2014-06-22

2.  Alteration of Clinical Chemistry Parameters Among Visceral Leishmaniasis Patients in Western Tigrai, Ethiopia, 2018/2019: A Comparative Cross-Sectional Study.

Authors:  Brhane Tesfanchal; Gebremedhin Gebremichail; Getachew Belay; Gebreslassie Gebremariam; Gebreyohannes Teklehaimanot; Hagos Haileslasie; Getachew Kahsu; Aderajew Gebrewahd; Fitsum Mardu; Gebre Adhanom; Brhane Berhe; Hirut Teame; Aster Tsegaye; Mistire Wolde
Journal:  Infect Drug Resist       Date:  2020-08-26       Impact factor: 4.003

3.  Effect of trinitroglycerin therapy on serum zinc and copper levels and liver enzyme activities in BALB/c mice infected with Leishmania major MRHO/IR/75/ER.

Authors:  Mana Najafzade; Abbas Mosapour; Hossein Nahrevanian; Zahra Zamani; Seifoddin Javadian; Fatemeh Mirkhani
Journal:  Iran J Basic Med Sci       Date:  2015-03       Impact factor: 2.699

4.  Historical series of patients with visceral leishmaniasis treated with meglumine antimoniate in a hospital for tropical diseases, Maceió-AL, Brazil.

Authors:  Lindon Johoson Diniz Silveira; Thiago José Matos Rocha; Sandra Aparecida Ribeiro; Célia Maria Silva Pedrosa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jan-Feb       Impact factor: 1.846

5.  Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia.

Authors:  Charles Abongomera; Koert Ritmeijer; Florian Vogt; Jozefien Buyze; Zelalem Mekonnen; Henok Admassu; Robert Colebunders; Rezika Mohammed; Lutgarde Lynen; Ermias Diro; Johan van Griensven
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.240

6.  Rising visceral leishmaniasis in Holy Himalayas (Uttarakhand, India) - A cross-sectional hospital-based study.

Authors:  Sweety Kumari; Piyush Dhawan; Prasan Kumar Panda; Mukesh Bairwa; Venkatesh S Pai
Journal:  J Family Med Prim Care       Date:  2020-03-26

7.  Assessment of liver function test and associated factors among visceral leishmaniasis patients attending university of gondar leishmaniasis research and treatment center, Northwest Ethiopia.

Authors:  Hiwot Tezera Endale; Tiget Ayelgn Mengstie; Dilargachew Dessie Dawit; Rezika Mohammed; Gashaw Dessie; Kibur Hunie Tesfa
Journal:  PLoS One       Date:  2021-11-19       Impact factor: 3.240

8.  Intravenous and subcutaneous toxicity and absorption kinetics in mice and dogs of the antileishmanial triterpene saponin PX-6518.

Authors:  Louis Maes
Journal:  Molecules       Date:  2013-04-22       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.